Investing Profile

Matthew McAviney

InvestorVC
Partner at New Enterprise Associates (NEA)
nea.com/team/matt-mcaviney-mdSan Francisco, California
Photo of Matthew McAviney, Partner at New Enterprise Associates (NEA)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$2.0M - $50.0M
$25.0M
6
$6.2B
CompanyStageDateRound SizeTotal Raised
CHARM Therapeutics
Series BSep 2025$80M
$130M
Co-investors: Alex Morgan (Khosla Ventures), Chris Bischoff (General Catalyst), Rishi Gupta (OrbiMed), Nihal Sinha (F-Prime Capital Partners), Muzammil Mansuri (F-Prime Capital Partners)
Ouro Medicines
Series AJan 2025$120M
$120M
Co-investors: Brian Matesic (Norwest Venture Partners), Shinichiro Fuse
AviadoBio
Series ADec 2021$78M
$78M
Sagimet Biosciences
Series UnknownFeb 2021$80M
$190M
Co-investors: Robert Garland (New Enterprise Associates (NEA)), Beth Seidenberg (Westlake Village BioPartners), David Mott (Mott Family Capital)
Korro Bio
SeedJan 2018
$210M
Co-investors: Jean-François Formela (Atlas Venture)
Moximed
SeedJan 2007
$200M
Co-investors: Tiffany Le (New Enterprise Associates (NEA)), Josh Makower (New Enterprise Associates (NEA)), Shahzad Malik (Advent Life Sciences)